A detailed history of Gables Capital Management Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Gables Capital Management Inc. holds 900 shares of NVO stock, worth $76,500. This represents 0.05% of its overall portfolio holdings.

Number of Shares
900
Holding current value
$76,500
% of portfolio
0.05%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$119.07 - $145.42 $107,163 - $130,877
900 New
900 $107,000
Q1 2023

May 03, 2023

SELL
$132.34 - $159.14 $26,468 - $31,827
-200 Reduced 33.33%
400 $63,000
Q4 2022

Feb 03, 2023

BUY
$102.55 - $135.33 $61,530 - $81,198
600 New
600 $81,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $192B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Gables Capital Management Inc. Portfolio

Follow Gables Capital Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gables Capital Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Gables Capital Management Inc. with notifications on news.